J. Edward Moreno
banner
jedwrdmoreno.bsky.social
J. Edward Moreno
@jedwrdmoreno.bsky.social
Reporter at @sherwood.news Say hi: [email protected]; (Signal) jedwardmoreno.04

https://sherwood.news/author/j-edward-moreno/
Reposted by J. Edward Moreno
Truly grateful for my time at Sherwood, where I worked with some of the best writers & editors in the business. It was a great ride and I'm proud of the innovative journalism we created.

Taking a break to enjoy the summer but would love to hear about good fits for the fall. bsky.app/profile/wsj....
June 17, 2026 at 12:37 PM
Reposted by J. Edward Moreno
Unfortunately my role was eliminated as part of these layoffs. Very proud of the work I did at Sherwood covering Big Tech and AI. Absolutely killer team of journalists that I loved working with. A thread of some of my favorite pieces...
June 16, 2026 at 7:51 PM
Reposted by J. Edward Moreno
Inside the cash-burning, uninsurable, and controversial plan to turn a pro-doping sporting event into a mainstream supplement empire.
https://sherwood.news/markets/the-enhanced-games-isnt-about-sports-its-a-31-million-product-demo/
The Enhanced Games isn’t just about sports — it’s a $31 million product demo
Inside the cash-burning, uninsurable, and controversial plan to turn a pro-doping sporting event into a mainstream supplement empire.
sherwood.news
May 21, 2026 at 9:15 AM
Reposted by J. Edward Moreno
Extremely excited to be debuting the EntryPoint newsletter today with @crowthski.bsky.social, who teases our launch party here:
sherwood.news/markets/robi...

Consider subscribing and adding to your premarket reading diet. It’s the only place w data on what Robinhood traders are buying and selling.
May 11, 2026 at 11:01 AM
Reposted by J. Edward Moreno
Very good @jedwrdmoreno.bsky.social on the market mechanics and finer policy points behind yesterday’s tumble in weed stocks sherwood.news/markets/doj-...
April 24, 2026 at 2:11 PM
Reposted by J. Edward Moreno
Honored for this honorable mention from SABEW’s Best In Business awards for my AI reporting (and @joshadams.bsky.social fantastic art for our Hyperion story). And @jedwrdmoreno.bsky.social did as well for his superb GLP-1 reporting. Exciting to see @sherwood.news punching above our weight!
March 25, 2026 at 6:45 PM
Reposted by J. Edward Moreno
Strive has already been probed over the timing of its GLP-1 compounding. Now, Arizona regulators are looking into complaints about ketamine misuse and improper distribution of prescription drugs. https://sherwood.news/business/exclusive-before-hims-glp-1-pill-fallout-its-pharmacy-partner-was-alread�
Exclusive: Before Hims’ GLP-1 pill fallout, its pharmacy partner was already drawing scrutiny from state regulators
Strive has already been probed over the timing of its GLP-1 compounding. Now, Arizona regulators are looking into complaints about ketamine misuse...
sherwood.news
February 13, 2026 at 5:20 PM
Reposted by J. Edward Moreno
great piece that lays out the context of a truly wild stock market and public health story sherwood.news/business/him...
Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy
It’s unclear if the pill Hims is selling works or if the FDA will allow it....
sherwood.news
February 6, 2026 at 4:09 PM
Reposted by J. Edward Moreno
WEIGHT LOST INTEREST

Ozempic’s soft power has been eclipsed by Zepbound
(via @jedwrdmoreno.bsky.social) sherwood.news/markets/ozem...
February 4, 2026 at 7:43 PM
Reposted by J. Edward Moreno
amazing amazing piece from @jonkeegan.com about how tech giants stack the deck in their favor when building out data centers with art from the one and only @joshadams.bsky.social sherwood.news/tech/hyperion/
The power play behind Hyperion, Mark Zuckerberg’s colossal data center being built in rural Louisiana
$10 billion of investment. Code names to disguise projects and companies. Mixed opinions. Skyrocketing property values. And enough tax breaks...
sherwood.news
December 15, 2025 at 2:45 PM
Reposted by J. Edward Moreno
No way this is true. Please contact me if you actually use Facebook dating and are a human. www.nytimes.com/2025/11/03/t...
Facebook Dating Is a Surprise Hit for the Social Network
www.nytimes.com
November 3, 2025 at 8:16 PM
Reposted by J. Edward Moreno
Really good read from sex, drugs, and rock n roll correspondent @jedwrdmoreno.bsky.social:

How upstart dating apps like Cerca are capitalizing on the “anti-swipe” moment sherwood.news/business/how...
How insurgent dating apps like Cerca are capitalizing on the “anti-swipe” moment
As people tire of swiping through hundreds of profiles, new VC-backed entrants as well as legacy apps are trying to shift toward quality over...
sherwood.news
October 14, 2025 at 2:09 PM
Reposted by J. Edward Moreno
My colleague @jedwrdmoreno.bsky.social is covering the hell out of the whole GLP-1 (Ozempic, etc) industry. He built this super interesting tracker to keep up with all the different drugs, their regulatory status and the results from their trials.
sherwood.news/business/who...
Who is winning the GLP-1 race?
It’s hard to keep track of all the next-gen GLP-1s in the pipeline, but we tried our best....
sherwood.news
September 19, 2025 at 7:50 PM
Reposted by J. Edward Moreno
I interviewed Slate Auto CEO Chris Barman this week. She told me why she thinks Slate can actually make a $25K electric truck and that I’d be able to wrap mine in hot pink for $500 sherwood.news/tech/slate-a...
Slate Auto CEO Chris Barman tells us how exactly it’s making a $25,000 EV
The automotive veteran explains why her company can deliver a cheap electric vehicle when others, like Tesla, have failed....
sherwood.news
July 11, 2025 at 4:37 PM
Eli Lilly appears to be fattening its stockpiles of GLP-1s as the threat of tariffs on pharmaceuticals looms. sherwood.news/world/eli-li...
July 8, 2025 at 6:30 PM
Grindr thinks there’s room for yet another ED telehealth brand. It might be right. sherwood.news/business/why...
Why Grindr decided to build a side hustle selling erectile dysfunction pills
From stoic Senator Bob Dole to racy ads targeting men on a gay dating app, erectile dysfunction marketing has changed wildly over the past three...
sherwood.news
July 8, 2025 at 3:40 PM
Reposted by J. Edward Moreno
Cuts to Medicaid and signs that ACA enrollees are becoming costlier are weighing on some insurers. Is Centene the canary in the coal mine?
https://sherwood.news/markets/selling-government-sponsored-insurance-is-looking-less-lucrative-its-about/
Selling government-sponsored insurance is looking less lucrative. It’s about to get even messier.
Cuts to Medicaid and signs that ACA enrollees are becoming costlier are weighing on some insurers. Is Centene the canary in the coal mine?...
sherwood.news
July 2, 2025 at 8:03 PM
Reposted by J. Edward Moreno
My colleague @jedwrdmoreno.bsky.social has been covering the hell out of these telehealth / pharma startups like Hims & Hers / Ro. He dives into the growth of “franken-pills” that combine ED+hair loss drugs via compounding which aren’t regulated or approved by the FDA. sherwood.news/business/the...
The controversial rise of Franken-pills: Telehealth companies push to mix meds in a single pill
Combination pills, like those that treat ED and hair loss at the same time, help companies like Hims & Hers and Ro with customer retention. But...
sherwood.news
June 13, 2025 at 3:08 PM
Reposted by J. Edward Moreno
🔮🤖 Some AI folks bold enough to predict when AGI (artificial general intelligence) will arrive — even though nobody can agree on a definition!

We’ve seen enough of these, so we decided to track some high-profile public statements with dates. (With @rani.bsky.social )

sherwood.news/tech/gi-arti...
June 12, 2025 at 4:04 PM
In the first quarter of 2025, $68.7 billion in pharmaceutical products were imported compared to $48.7 billion in the same quarter period last year.
May 6, 2025 at 5:46 PM
Reposted by J. Edward Moreno
many people are saying
May 6, 2025 at 5:02 PM
Reposted by J. Edward Moreno
The company has high short interest and the stock has risen significantly in the past week. Its earnings report could be make or break for short sellers.
https://sherwood.news/markets/is-a-hims-and-hers-short-squeeze-brewing/
Is a Hims & Hers short squeeze brewing?
The company has high short interest and the stock has risen significantly in the past week. Its earnings report could be make or break for short...
sherwood.news
May 5, 2025 at 6:03 PM
Reposted by J. Edward Moreno
Healthcare companies are paying out more...for security sherwood.news/power/health... @jedwrdmoreno.bsky.social
April 28, 2025 at 6:50 PM
Virtually every healthcare company that has filed a proxy statement so far this year reported increased spending on protecting their executives in 2024.
April 28, 2025 at 6:14 PM